nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments
|
Wagner, Angelika |
|
|
39 |
51 |
p. 7375-7378 |
artikel |
2 |
A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine
|
Ye, Ke |
|
|
39 |
51 |
p. 7470-7476 |
artikel |
3 |
An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella
|
Siggins, Matthew K. |
|
|
39 |
51 |
p. 7503-7509 |
artikel |
4 |
An oral vaccine based on chitosan/aluminum adjuvant induces both local and systemic immune responses in turbot (Scophthalmus maximus)
|
Jin, Peng |
|
|
39 |
51 |
p. 7477-7484 |
artikel |
5 |
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination
|
Cannon, Kevin |
|
|
39 |
51 |
p. 7494-7502 |
artikel |
6 |
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
|
Vizcarra, Pilar |
|
|
39 |
51 |
p. 7367-7374 |
artikel |
7 |
COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals?
|
Harpaz, Rafael |
|
|
39 |
51 |
p. 7366 |
artikel |
8 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
51 |
p. IFC |
artikel |
9 |
Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens
|
Vohra, Prerna |
|
|
39 |
51 |
p. 7413-7420 |
artikel |
10 |
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France
|
Ribera-Cano, Anna |
|
|
39 |
51 |
p. 7441-7445 |
artikel |
11 |
Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine
|
Colombatti Olivieri, María Alejandra |
|
|
39 |
51 |
p. 7401-7412 |
artikel |
12 |
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo
|
Hoff, Nicole A. |
|
|
39 |
51 |
p. 7464-7469 |
artikel |
13 |
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12–13 February 2020
|
Voss, Gerald |
|
|
39 |
51 |
p. 7357-7362 |
artikel |
14 |
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates
|
Li, Hualin |
|
|
39 |
51 |
p. 7446-7456 |
artikel |
15 |
Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states
|
Vasudevan, Lavanya |
|
|
39 |
51 |
p. 7485-7493 |
artikel |
16 |
Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine
|
Aw, Rochelle |
|
|
39 |
51 |
p. 7379-7386 |
artikel |
17 |
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
|
Lau, Colleen L. |
|
|
39 |
51 |
p. 7429-7440 |
artikel |
18 |
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques
|
Sun, Peifang |
|
|
39 |
51 |
p. 7510-7520 |
artikel |
19 |
Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama
|
Shah, Sayyed Fawad Ali |
|
|
39 |
51 |
p. 7421-7428 |
artikel |
20 |
Vaccination of healthcare personnel in the COVID-19 era: A call for actions
|
Maltezou, Helena C. |
|
|
39 |
51 |
p. 7363-7365 |
artikel |
21 |
Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants – A claims database analysis in Germany
|
Laurenz, Maren |
|
|
39 |
51 |
p. 7387-7393 |
artikel |
22 |
Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story
|
Radwan, Naglaa Fathy |
|
|
39 |
51 |
p. 7457-7463 |
artikel |
23 |
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
|
Wu, Kai |
|
|
39 |
51 |
p. 7394-7400 |
artikel |